GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Forward PE Ratio

Renhe Pharmacy Co (SZSE:000650) Forward PE Ratio : 0.00 (As of Jun. 06, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Forward PE Ratio?

Renhe Pharmacy Co's Forward PE Ratio for today is 0.00.

Renhe Pharmacy Co's PE Ratio without NRI for today is 12.59.

Renhe Pharmacy Co's PE Ratio for today is 16.34.


Renhe Pharmacy Co Forward PE Ratio Historical Data

The historical data trend for Renhe Pharmacy Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Forward PE Ratio Chart

Renhe Pharmacy Co Annual Data
Trend
Forward PE Ratio

Renhe Pharmacy Co Quarterly Data
Forward PE Ratio

Competitive Comparison of Renhe Pharmacy Co's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Renhe Pharmacy Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renhe Pharmacy Co's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renhe Pharmacy Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Renhe Pharmacy Co's Forward PE Ratio falls into.



Renhe Pharmacy Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Renhe Pharmacy Co  (SZSE:000650) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Renhe Pharmacy Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Renhe Pharmacy Co (SZSE:000650) Business Description

Traded in Other Exchanges
N/A
Address
No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.
Executives
Yang Xiao Director
Kang Zhi Hua Supervisors
Mei Qiang Directors, executives
Yang Wen Long Director

Renhe Pharmacy Co (SZSE:000650) Headlines

No Headlines